MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-06-2026
Mettler-Toledo International EBITDA per Share 2011-2026 | MTD
Annual EBITDA per Share Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.48 | 2.37 | 2.24 | 2.08 | 1.94 | 1.76 | 31.7 | 29 | 25.5 | 22 | 19.2 | 17.5 | 15.8 | 14.3 | 12.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.7 | 1.76 | 13.4 |
Quarterly EBITDA per Share Mettler-Toledo International
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.62 | 0.62 | 0.6 | - | 0.61 | 0.58 | 0.58 | - | 0.32 | 0.31 | 0.54 | - | 0.3 | 0.29 | 0.52 | - | 1.45 | 0.27 | 0.47 | - | 1.29 | 0.85 | 0.42 | - | 1.2 | 0.79 | 0.39 | - | 1.11 | 0.74 | 0.36 | - | 0.95 | 0.62 | 0.31 | - | 0.93 | 0.61 | 0.3 | - | 0.91 | 0.6 | 0.3 | - | 0.89 | 0.58 | 0.29 | - | 0.87 | 0.58 | 0.29 | - | 0.79 | 0.52 | 0.25 | - | 0.76 | 0.48 | 0.23 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.45 | 0.23 | 0.606 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 19.89 | 10.93 % | $ 211 M |  China |
 |
Agilent Technologies
A
|
5.49 | $ 120.39 | 2.46 % | $ 36.6 B |  USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 17.63 | 4.75 % | $ 939 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 1.38 | -4.83 % | $ 1.84 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 24.37 | 3.57 % | $ 677 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 179.31 | 0.54 % | $ 8.89 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 2.2 | - | $ 9.73 M | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 198.61 | 1.4 % | $ 142 B | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-3.01 | $ 130.32 | 2.65 % | $ 20.7 B | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 520.0 | 3.74 % | $ 15 B | USA |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 16.02 | 4.71 % | $ 484 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
0.61 | $ 29.09 | 1.89 % | $ 20 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Guardant Health
GH
|
-3.17 | $ 86.4 | 5.1 % | $ 10.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.91 | 6.97 % | $ 455 M | USA |
 |
Anixa Biosciences
ANIX
|
-361 | $ 2.88 | 1.05 % | $ 93.5 K | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.1 | 0.96 % | $ 4.82 M | USA |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.75 | 0.45 % | $ 282 M | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 113.06 | 2.44 % | $ 9.33 B |  Irlanda |
 |
NeoGenomics
NEO
|
-0.62 | $ 8.35 | 4.38 % | $ 1.07 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 268.87 | 1.78 % | $ 22.4 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 120.85 | 0.37 % | $ 5.65 B | USA |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.61 | 5.14 % | $ 2.08 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 82.74 | 1.31 % | $ 5.58 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 194.16 | 0.65 % | $ 21.6 B | USA |
 |
Natera
NTRA
|
-5.33 | $ 214.64 | 6.31 % | $ 21.1 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.27 | $ 4.96 | -4.43 % | $ 3.9 M | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 17.04 | 1.34 % | $ 381 M | USA |
 |
Organovo Holdings
ONVO
|
-8.44 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
0.11 | - | -16.95 % | $ 1.54 M | USA |